| Year | Sales (Million USD) | Year-on-Year Variation (%) |
|---|---|---|
| 2024 | 287.0 | N/A |
| 2025 | 293.0 | 2.09% |
| 2026 | 298.9 | 2.01% |
| 2027 | 304.6 | 1.91% |
| 2028 | 310.1 | 1.81% |
The Compound Annual Growth Rate (CAGR) over the next five years (2024–2028) is approximately 1.96%.
Future Trends to Watch
The genito urinary system and sex hormones market in Chile is projected to exhibit steady growth. Factors such as advancements in medical treatments, increased healthcare investments, and a growing aging population will likely drive demand. Case studies should be monitored for the impact of new hormonal therapies and socio-economic changes influencing healthcare access.
